Smartleaf Asset Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.8K Hold
534
﹤0.01% 2077
2026
Q1
$10K Sell
534
-275
-34% -$6.5K ﹤0.01% 2329
2025
Q4
$26.7K Sell
809
-107
-12% -$4.58K ﹤0.01% 1878
2025
Q3
$54.2K Buy
916
+283
+45% +$14.5K ﹤0.01% 1356
2025
Q2
$31.3K Sell
633
-1,039
-62% -$47K ﹤0.01% 1365
2025
Q1
$48.7K Buy
1,672
+227
+16% +$8.43K ﹤0.01% 1161
2024
Q4
$36.4K Buy
1,445
+1,413
+4,416% +$35K ﹤0.01% 1329
2024
Q3
$568 Buy
+32
New +$573 ﹤0.01% 2767

Other funds holding HIMS

Smartleaf Asset Management's HIMS Position: Q2 2026 in Review

Smartleaf Asset Management held its Hims & Hers Health (HIMS) position steady in Q2 2026 at 534 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Smartleaf Asset Management first reported a position in HIMS in Q3 2024 and has held it in 8 quarters since. The position peaked at $54.2K in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Smartleaf Asset Management held 534 shares of Hims & Hers Health worth $17.8K as of Q2 2026.
  • Smartleaf Asset Management left its Hims & Hers Health share count unchanged in Q2 2026.
  • Hims & Hers Health made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2077 holding.
  • Smartleaf Asset Management first reported a position in Hims & Hers Health in Q3 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Hims & Hers Health position peaked at $54.2K in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.